US 12162855
Tetrahydroquinolino derivatives for the treatment of metastatic and chemoresistant cancers
granted A61PA61P35/00
Quick answer
US patent 12162855 (Tetrahydroquinolino derivatives for the treatment of metastatic and chemoresistant cancers) held by THE TRUSTEES OF PRINCETON UNIVERSITY expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE TRUSTEES OF PRINCETON UNIVERSITY
- Grant date
- Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61P, A61P35/00